Tag: ovid therapeutics

January 7, 2020

Ovid Provides 2020 Update for Rare Neurological Disease Platform

Ovid Therapeutics provided investors with an overview of its key clinical and business priorities for 2020.
December 1, 2019

5 Top NASDAQ Biotech and Pharma Stocks: Sorrento Climbs

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
November 8, 2019

Ovid Therapeutics Reports Q3 Financial Results

Ovid Therapeutics (NASDAQ:OVID) has announced its financial results for Q3 2019 ended September 30. As quoted in the press release:...
September 29, 2019

5 Top NASDAQ Biotech and Pharma Stocks: Big Rise for Ovid Therapeutics

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
September 12, 2019

Ovid Therapeutics’ First Patient Randomized in Pivotal Phase 3 NEPTUNE Trial

Ovid Therapeutics (NASDAQ:OVID) has announced it has randomized the first patient in its Phase 3 NEPTUNE clinical trial of OV101...
July 7, 2019

5 Top Weekly NASDAQ Biotech & Pharma Stocks: Corvus Soars

Which companies were on the rise last week? We take a look at the top five biotech and pharma stocks...
July 2, 2019

Ovid Therapeutics Receives Orphan Drug Designation from the European Commission for OV101

Ovid Therapeutics (NASDAQ:OVID) has announced that the European Commission granted the company orphan designation for OV101 to treat Angelman syndrome....